Powder: -20°C for 3 years | In solvent: -80°C for 1 year
S 2101 is an inhibitor of lysine-specific demethylase 1 (LSD1)(IC50 of 0.99 μM, Ki of 0.61 μM and Kinact/Ki of 4560 M/s).
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
2 mg | ¥ 1,180 | 5日内发货 | ||
5 mg | ¥ 1,990 | 5日内发货 | ||
25 mg | ¥ 6,910 | 6-8周 | ||
50 mg | ¥ 9,170 | 6-8周 | ||
100 mg | ¥ 14,200 | 6-8周 |
产品描述 | S 2101 is an inhibitor of lysine-specific demethylase 1 (LSD1)(IC50 of 0.99 μM, Ki of 0.61 μM and Kinact/Ki of 4560 M/s). |
靶点活性 | LSD1:(ki)0.61 μM , LSD1:0.99 μM |
体外活性 | S 2101 is an inhibitor of lysine-specific demethylase 1 (LSD1)(IC50 of 0.99 μM, Ki of 0.61 μM and Kinact/Ki of 4560 M/s). S 2101 also displays much lower inhibition activity toward MAO-B with Ki of 17 μM and Kinact/Ki of 18 M/s and MAO-A (Ki=110 μM, Kinact/Ki=60 M/s). The treatment of HEK293T cells with S 2101 results in a dose-dependent increase in the level of H3K4me2, which must have accumulated by the inactivation of LSD1. During the course of S 2101 treatment, the amounts of histone H3 and LSD1 in the nuclear extracts remain essentially unaffected. Because the treatment with 1 μM S 2101 generates a level of H3K4me2 similar to that elicited by 50 μM 2-PCPA, In human cells, S 2101 is assumed to have approximately 50-fold stronger LSD1 inhibition activity than 2-PCPA . |
别名 | S 2101 |
分子量 | 311.75 |
分子式 | C16H16ClF2NO |
CAS No. | 1239262-36-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
S2101 1239262-36-2 Chromatin/Epigenetic Histone Demethylase S 2101 S-2101 Inhibitor inhibitor inhibit